LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio - StreetInsider
9/10LumaCina appointed Gary Bird as its new CEO on July 14, 2026, aiming to accelerate company growth and expand its global sterile injectables portfolio. This leadership change reflects a strategic focus on pharmaceutical sector expansion.
